Iterative Health

Summary active Updated Apr 30, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Cambridge, MA
Latest Stage Series C
Total Raised $77M (Series C)

Investors

Vishal Vasishth Early Stage (2021)
GV (Google Ventures) series-c (2026)
Insight Partners series-c (2026)
Obvious Ventures series-c (2026)

Founders

Jonathan Ng Founder & CEO

About

Iterative Health is a Cambridge, Massachusetts-based healthcare technology and services company building an AI-driven multispecialty clinical research network 1. Founded by Jonathan Ng, the company began in gastroenterology and hepatology and has expanded to cardiology and obesity, with more than 100 research sites across North America, Europe, India, and Australia 12. On April 30, 2026, the company closed a $77 million Series C, reportedly valuing it at approximately $1.3 billion post-money 123.

Funding History

Date Round Amount Lead Co-investors
2026-04-30 Series C $77M Intrepid Growth Partners, GV EDBI, Insight Partners, Obvious Ventures 123

What Investors Say

No independently sourced investor quotes found.

What Founders Say

“Every delay in a clinical trial is a delay for patients whose outcomes depend on faster access to innovation. By keeping our physician partners and their patients at the center of our model, we’ve built a system that delivers high-performance site execution at scale.” — Jonathan Ng, Founder and CEO, April 30, 2026 1.

Sources


  1. BioSpace / Business Wire, “Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research,” April 30, 2026, accessed April 2026. https://www.biospace.com/press-releases/iterative-health-closes-77-million-series-c-to-accelerate-the-future-of-clinical-research

  2. Pulse2, “Iterative Health: $77 Million Raised To Scale Multispecialty Clinical Research Network Powered By AI,” April 30, 2026, accessed April 2026. https://pulse2.com/iterative-health-77-million-raised-to-scale-multispecialty-clinical-research-network-powered-by-ai/

  3. Axios Pro Rata, “Iterative Health collects $77m, Versana’s $43m for loan market infrastructure, and GTCR builds Avelis,” April 30, 2026, accessed April 2026. https://www.axios.com/pro/all-deals/2026/04/30/pro-rata-premium-first-look-iterative-versana-gtcr